Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Pierre Fenaux

20PUBLICATIONS
93CO-AUTHORS
Respiratory diseasesHaematological tumoursMedical virologyCancer therapy (excl. chemotherapy and radiation therapy)Cardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

Sort by Publication Date:
|Feb 18, 2026
Clinical outcomes of patients with lower risk myelodysplastic syndrome from EUMDS registry eligible for transplantation: Implications for transplantation strategies.

Aleksandar Savic, Adele Taylor, Pierre Fenaux

|Jul 02, 2025
Efficacy and safety of luspatercept with or without erythropoiesis-stimulating agent in patients with myelodysplastic neoplasms with ring sideroblasts: A multicentre real-life study by the GFM.

Maud D'Aveni, Laurence Schenone, Jose Miguel Torregrosa

|Dec 19, 2024
Olutasidenib demonstrates significant clinical activity in mutated IDH1 acute myeloid leukaemia arising from a prior myeloproliferative neoplasm.

Stéphane De Botton, Christian Récher, Jorge Cortes

|Aug 01, 2024
Targeting the redox vulnerability of acute myeloid leukaemia cells with a combination of auranofin and vitamin C.

Zhiliang Hei, Shujun Yang, Guifang Ouyang

|Dec 22, 2022
Reduced murine double minute 2 and 4 protein, but not messenger RNA, expression is associated with more severe disease in myelodysplastic syndromes and acute myeloblastic leukaemia.

Norman Salomao, Nabih Maslah, Anouk Giulianelli

|Nov 06, 2022
Cause of death and excess mortality in patients with lower-risk myelodysplastic syndromes (MDS): A report from the European MDS registry.

Krzysztof Mądry, Karol Lis, Pierre Fenaux

Pageof 4

Frequent Collaborators

3 joint publications

Lionel Adès

3 joint publications

Sophie Park

3 joint publications

Thibault Comont

3 joint publications

Pierre Peterlin

2 joint publications

María Díez-Campelo

2 joint publications

Kamel Laribi

2 joint publications

Aspassia Stamatoullas

2 joint publications

Reinhard Stauder

2 joint publications

Thierry Guillaume

2 joint publications

Thomas Cluzeau

Frequent Collaborators

3 joint publications

Lionel Adès

3 joint publications

Sophie Park

3 joint publications

Thibault Comont

3 joint publications

Pierre Peterlin

Top Related Videos

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on : Oct 03, 2018

10.2K
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on : Mar 26, 2018

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas
06:27

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas

Published on : May 09, 2025

233
See more related videos

Top Related Videos

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on : Oct 03, 2018

10.2K
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on : Mar 26, 2018

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas
06:27

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas

Published on : May 09, 2025

233
See more related videos